Kardigan, Inc.
KARD
IPO
$20.20
-$1.61-7.38%
NASDAQ
IPO Factors
Debt Ratio
Growth Ratio
Industry
Institutional Support
Investment
IPO Size
Management
Market Reaction
Profitability
Revenue
Revenue Growth
Syndicate Size
Valuation
Headlines
8/15/2026
-
MarketBeat
8/11/2026
-
GuruFocus
8/11/2026
-
TipRanks: TheFly
8/11/2026
-
Business Wire
8/11/2026
-
MarketBeat
7/21/2026
-
MarketBeat
7/17/2026
-
MarketBeat
7/16/2026
-
MarketBeat
7/14/2026
-
The Cerbat Gem
7/13/2026
-
TipRanks: TheFly
7/13/2026
-
TipRanks
6/22/2026
-
Business Wire
6/18/2026
-
Business Wire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, August 11, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Jun 7 and 11 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(415) 573-3220
Address
506 Carnegie Center Drive
Suite 201
Princeton, NJ 08540
Suite 201
Princeton, NJ 08540
Country
Year Founded
Business Description
Sector
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the...
more